NIH VideoCast - Relief from severe depression and suicidal ideation within hours: from synapses to symptoms

Skip Navigation

Relief from severe depression and suicidal ideation within hours: from synapses to symptoms

Loading... Loading video...

561 Views

Air date:	Wednesday, November 4, 2015, 3:00:00 PM Time displayed is Eastern Time, Washington DC Local
Views:	Total views: 561 (196 Live, 365 On-demand)
Category:	WALS - Wednesday Afternoon Lectures
Runtime:	01:04:09
Closed captioning:	Check box to display CC outside of the video Note: You can drag the captioning window around and resize it
Description:	NIH Director's Wednesday Afternoon Lecture Series Dr. Zarate's current research focus is on developing novel medications for treatment-resistant depression and bipolar disorder. His areas of expertise include biological and pharmacological aspects of mood disorders in adults. Dr. Zarate's group conducts proof-of-concept studies utilizing novel compounds and biomarkers (magnetoencephalography [MEG] and polysomnography [PSG], positron emission tomography, functional MRI and magnetic resonance spectroscopy [MRS]) to identify potentially relevant drug targets and biosignatures of treatment response. A multidisciplinary translational research team conducts the research in the ETPB. In addition, the Branch provides training to develop the next generation of clinical translational researchers. The Astute Clinician Lecture Series:The Astute Clinician Lecture was established through a gift from the late Dr. Robert W. Miller and his wife, Haruko. It honors a US clinician-scientist who has observed an unusual clinical occurrence, and by investigating it, has opened an important new avenue of research. For more information go to https://oir.nih.gov/wals/2015-2016/relief-severe-depression-suicidal-ideation-within-hours-synapses-symptoms

NLM Title:	Relief from severe depression and suicidal ideation within hours : from synapses to symptoms / Carlos Zarate.
Author:	Zarate, Carlos A. National Institutes of Health (U.S.),
Publisher:
Abstract:	(CIT): Dr. Zarate's current research focus is on developing novel medications for treatment-resistant depression and bipolar disorder. His areas of expertise include biological and pharmacological aspects of mood disorders in adults. Dr. Zarate's group conducts proof-of-concept studies utilizing novel compounds and biomarkers (magnetoencephalography [MEG] and polysomnography [PSG], positron emission tomography, functional MRI and magnetic resonance spectroscopy [MRS]) to identify potentially relevant drug targets and biosignatures of treatment response. A multidisciplinary translational research team conducts the research in the ETPB. In addition, the Branch provides training to develop the next generation of clinical translational researchers. The Astute Clinician Lecture Series:The Astute Clinician Lecture was established through a gift from the late Dr. Robert W. Miller and his wife, Haruko. It honors a US clinician-scientist who has observed an unusual clinical occurrence, and by investigating it, has opened an important new avenue of research.
Subjects:	Antidepressive Agents--therapeutic use Depressive Disorder, Major--drug therapy Drug Discovery Ketamine--therapeutic use Suicidal Ideation
Publication Types:	Lecture Webcast

NLM Classification:	WM 207
NLM ID:	101673090
CIT Live ID:	17559
Permanent link:	https://videocast.nih.gov/watch=17559

Related Videos...